Cinco, Kean Crizjay .
HRN: 14-05-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2022
CEFTRIAXONE 1G (VIAL)
07/12/2022
07/18/2022
IV DRIP
3gms
Q24
Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Disseminated Systemic Infection Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes